van Leeuwen A, Termijtelen A, Shaw S, van Rood J J
Nature. 1982 Aug 5;298(5874):565-7. doi: 10.1038/298565a0.
The serological recognition of 'new' gene products of the HLA system can be accomplished by selecting sera with strong leucocyte antibodies and testing these against a panel of cells obtained from donors which are compatible for the known HLA antigens with the antibody producer. This approach, which we termed the HLA-CAP approach (compatible with antibody producer), was essential in the recognition of what is now called the HLA-DR locus and of non HLA-linked T-cell subgroups. Using the same technique, we have defined here several sera recognizing a structure on monocytes similar to one of the alleles of the HLA-linked PL3 or secondary B-cell (SB) system, so far only recognized by cellular techniques.
通过选择具有强效白细胞抗体的血清,并将这些血清与从供体获得的一组细胞进行检测,这些供体的已知HLA抗原与抗体产生者相匹配,就可以实现对HLA系统“新”基因产物的血清学识别。我们将这种方法称为HLA - CAP方法(与抗体产生者相容),它对于识别现在所称的HLA - DR位点以及非HLA连锁的T细胞亚群至关重要。使用相同的技术,我们在此定义了几种血清,它们识别单核细胞上的一种结构,该结构类似于HLA连锁的PL3或二级B细胞(SB)系统的一个等位基因,迄今为止仅通过细胞技术识别。